ArticleInternational journal of molecular sciences2022

Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment.

Thorsten H Ecke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.